UCB's Global Corporate Website


Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Atopic Dermatitis A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B) Phase1/2 UP0110